Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI

Journal of Cardiovascular Magnetic Resonance

Volumn 15, Issue 1, 2013, Pages

  Piechnik, Stefan K ^a   Ferreira, Vanessa M ^a,b   Lewandowski, Adam J ^a   Ntusi, Ntobeko Ab ^a   Banerjee, Rajarshi ^a   Holloway, Cameron ^a   Hofman, Mark Bm ^c   Sado, Daniel M ^d   Maestrini, Viviana ^d   White, Steven K ^d   Lazdam, Merzaka ^a   Karamitsos, Theodoros ^a   Moon, James C ^d   Neubauer, Stefan ^a   Leeson, Paul ^a   Robson, Matthew D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFACT; BLOOD; BLOOD VOLUME; BODY SIZE; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD; FEMALE; HEART MUSCLE RELAXATION; HEART RATE; HEMATOCRIT; HUMAN; IMAGE ANALYSIS; MALE; MEASUREMENT; NORMAL HUMAN; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SHORTENED MODIFIED LOOK LOCKER INVERSION RECOVERY;

EID: 84872358923     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-15-13     Document Type: Article

References (30)

1. Physiologic basis of magnetic relaxation. Fullerton GD, Magnetic resonance imaging St. Louis; London: Mosby, Stark DD, Bradley WG, 2 1992 88 108
2. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM, Med Phys 1984 11 4 425 448 10.1118/1.595535 6482839 (Pubitemid 14057394)
3. Cardiovascular magnetic resonance by non contrast T1 mapping allows assessment of severity of injury in acute myocardial infarction. Dall'Armellina E, Piechnik S, Ferreira V, Si QL, Robson M, Francis J, Cuculi F, Kharbanda R, Banning A, Choudhury R, J Cardiovasc Magn Reson 2012 14 1 15 10.1186/1532-429X-14-15 22309452
4. Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Messroghli DR, Walters K, Plein S, Sparrow P, Friedrich MG, Ridgway JP, Sivananthan MU, Magn Reson Med 2007 58 1 34 40 10.1002/mrm.21272 17659622 (Pubitemid 47229915)
5. The diagnostic performance of non-contrast T1-mapping in patients with acute myocarditis on cardiovascular magnetic resonance imaging. Ferreira V, Piechnik S, Dall'Armellina E, Karamitsos T, Francis J, Choudhury R, Kardos A, Friedrich M, Robson M, Neubauer S, J Cardiovasc Magn Reson 2012 14 Suppl 1 179
6. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ, J Cardiovasc Magn Reson 2008 10 54 10.1186/1532-429X-10-54 19032744
7. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ, J Am Coll Cardiol 2008 52 19 1574 1580 10.1016/j.jacc.2008.06.049 19007595
8. Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. Sparrow P, Messroghli DR, Reid S, Ridgway JP, Bainbridge G, Sivananthan MU, AJR Am J Roentgenol 2006 187 6 630 W635 10.2214/AJR.05.1264 17114517
9. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: Preliminary validation in humans. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC, Circulation 2010 122 2 138 144 10.1161/CIRCULATIONAHA.109.930636 20585010
10. Myocardial tissue characterization using magnetic resonance Non-contrast T1 mapping in hypertrophic and dilated cardiomyopathy. Dass S, Suttie JJ, Piechnik SK, Ferreira VM, Holloway CJ, Banerjee R, Mahmod M, Cochlin L, Karamitsos TD, Robson MD, Circ Cardiovasc Imaging 2012 5 726 733 published online before print October 15 2012 10.1161/CIRCIMAGING.112.976738 23071146
11. Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis. Karamitsos T, Banypersad S, Sado D, Maestrini V, Ferreira V, Piechnik S, Robson M, Hawkins P, Neubauer S, Moon J, J Cardiovasc Magn Reson 2012 14 Suppl 1 76 10.1186/1532-429X-14-S1-O76
12. Shortened modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 And 3 T within a 9 heartbeat breathhold. Piechnik SK, Ferreira VM, Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD, J Cardiovasc Magn Reson 2010 12 69 10.1186/1532-429X-12-69 21092095
13. Steady-state free precession with myocardial tagging: CSPAMM in a single breathhold. Zwanenburg JJ, Kuijer JP, Marcus JT, Heethaar RM, Magn Reson Med 2003 49 4 722 730 10.1002/mrm.10422 12652544 (Pubitemid 36389983)
14. Selective population inversion in NMR. Silver MS, Joseph RI, Chen CN, Sank VJ, Hoult DI, Nature 1984 310 5979 681 683 10.1038/310681a0 6472448
15. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. Ferreira VM, Piechnik SK, Dall'armellina E, Karamitsos TD, Francis JM, Choudhury RP, Friedrich MG, Robson MD, Neubauer SM, J Cardiovasc Magn Reson 2012 14 1 42 10.1186/1532-429X-14-42 22720998
16. Statistical methods for assessing agreement between two methods of clinical measurement. Bland JM, Altman DG, Lancet 1986 1 8476 307 310 2868172 (Pubitemid 16134762)
17. Water exchange across red cell membranes: II. Measurements by nuclear magnetic resonance T1, T2, and T12 hybrid relaxation. The effects of osmolarity, cell volume, and medium. Fabry ME, Eisenstadt M, J Membr Biol 1978 42 4 375 398 10.1007/BF01870357 702523 (Pubitemid 9022174)
18. First-pass entry of nonionic contrast agent into the myocardial extravascular space. Canty JM Jr, Judd RM, Brody AS, Klocke FJ, Effects on radiographic estimates of transit time and blood volume. Circulation 1991 84 5 2071 2078
19. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. Ugander M, Bagi PS, Oki AJ, Chen B, Hsu LY, Aletras AH, Shah S, Greiser A, Kellman P, Arai AE, JACC Cardiovasc Imaging 2012 5 6 596 603 10.1016/j.jcmg.2012.01.016 22698528
20. Partition coefficients for gadolinium chelates in the normal myocardium: Comparison of gadopentetate dimeglumine and gadobenate dimeglumine. Kawel N, Nacif M, Santini F, Liu S, Bremerich J, Arai AE, Bluemke DA, J Magn Reson Imaging 2012 36 3 733 737 10.1002/jmri.23651 22488770
21. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley C, Bluemke D, J Cardiovasc Magn Reson 2012 14 1 26 10.1186/1532-429X-14-26 22540153
22. Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Xue H, Shah S, Greiser A, Guetter C, Littmann A, Jolly MP, Arai AE, Zuehlsdorff S, Guehring J, Kellman P, Magn Reson Med 2012 67 6 1644 1655 10.1002/mrm.23153 22135227
23. Quantification of acute myocardial injury by ShMOLLI T1-Mapping, T2-weighted and late gadolinium imaging in patients presenting with chest pain, positive troponins and non-obstructive coronary arteries. Ferreira V, Piechnik S, Dall'Armellina E, Karamitsos T, Francis J, Friedrich M, Robson M, Neubauer S, J Cardiovasc Magn Reson 2011 13 Suppl 1 16 10.1186/1532-429X-13-S1-P16
24. Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP, Magn Reson Med 2004 52 1 141 146 10.1002/mrm.20110 15236377 (Pubitemid 39295266)
25. Myocardial T1 and extracellular volume fraction mapping at 3 tesla. Lee JJ, Liu S, Nacif MS, Ugander M, Han J, Kawel N, Sibley CT, Kellman P, Arai AE, Bluemke DA, J Cardiovasc Magn Reson 2011 13 75 10.1186/1532-429X-13-75 22123333
26. Human myocardium: Single-breath-hold MR T1 mapping with high spatial resolution-Reproducibility study. Messroghli DR, Plein S, Higgins DM, Walters K, Jones TR, Ridgway JP, Sivananthan MU, Radiology 2006 238 3 1004 1012 10.1148/radiol.2382041903 16424239 (Pubitemid 43289933)
27. Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences. Nacif MS, Turkbey EB, Gai N, Nazarian S, van der Geest RJ, Noureldin RA, Sibley CT, Ugander M, Liu S, Arai AE, J Magn Reson Imaging 2011 34 6 1367 1373 10.1002/jmri.22753 21954119
28. T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley C, Bluemke D, J Cardiovasc Magn Reson 2012 14 1 27 10.1186/1532-429X-14-27 22548832
29. T2-dependent errors in MOLLI T1 values: simulations, phantoms, and in-vivo studies. Chow K, Flewitt J, Pagano J, Green J, Friedrich M, Thompson R, J Cardiovasc Magn Reson 2012 14 Suppl 1 281 10.1186/1532-429X-14-S1-P281
30. Inversion recovery at 7 Tesla in the human myocardium: measurement of T1, inversion efficiency and B1+. Rodgers CT, Piechnik SK, DelaBarre LJ, Van de Moortele P, Snyder C, Neubauer S, Robson MD, Vaughan JT, Magn Reson Med 2012 2012 Article first published online: 29 NOV 2012 10.1002/mrm.24548